Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $285.75 USD
Change Today -4.06 / -1.40%
Volume 1.9M
As of 8:04 PM 05/5/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Paul M. Bisaro

Executive Chairman, Actavis plc
AgeTotal Calculated CompensationThis person is connected to 53 board members in 6 different organizations across 10 different industries.

See Board Relationships
53$35,890,666
As of Fiscal Year 2014

Background*

Mr. Paul M. Bisaro has been the Executive Chairman of Actavis plc since July 2014. Mr. Bisaro served as Chief Executive Officer and President of Actavis plc from September 4, 2007 to July 2014, its Chairman of the Board from October 2013 to July 2014. He served as the Chief Executive Officer, President and Chairman at Actavis Limited since October 2013. He served as the President and Chief Operating Officer of Teva Branded Pharmaceutical Products R&D, Inc. (fromerly, ...

Read Full Background

Corporate Headquarters*

Euro House
Little Island, Co. Cork --

Ireland

Phone: 353 21 461 9040
Fax: 353 21 461 9049

Board Members Memberships*

Independent Director
Director
1998-N/A
Former President, Chief Operating Officer, Director, President of New BLI and Chief Operating Officer of New BLI
2007-Present
Executive Chairman
2013-Present
Independent Director, Member of Compensation & Management Development Committee and Member of Corporate Governance Committee
2013-Present
Chairman, Chief Executive Officer and President
2015-Present
Director

Education*

Bachelor's Degree 1983
University of Michigan
JD 1989
Catholic University of America

Other Affiliations*

Annual Compensation*

Salary$1,025,000
Total Annual Compensation$1,025,000

Stock Options*

Restricted Stock Awards$25,641,217
All Other Compensation$123,137
Unexercisable Options78,029
Total Number of Options78,029

Total Compensation*

Total Annual Cash Compensation$3,847,950
Total Short Term Compensation$1,025,000
Other Long Term Compensation$25,764,354
Total Calculated Compensation$35,890,666
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACT:US $285.75 USD -4.06

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Giovanni Caforio M.D.Chief Executive Officer, Chief Operating Officer and Director
Bristol-Myers Squibb Company
$916.0K
Omar S. Ishrak Chairman and Chief Executive Officer
Medtronic plc
$1.5M
Andrew Philip Witty Chief Executive Officer, Executive Director and Member of Finance Committee
GlaxoSmithKline plc
2.0M GBP
Lars Rebien Sørensen Chief Executive Officer and Member of Executive Management
Novo Nordisk A/S
kr15.2M
J. Michael Pearson Chairman and Chief Executive Officer
Valeant Pharmaceuticals International, Inc.
$1.9M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACTAVIS PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.